Stability test of novel combined formulated dry powder inhalation system containing antibiotic physical characterization and in vitro–in silico lung deposition results /

QR kód

Stability test of novel combined formulated dry powder inhalation system containing antibiotic physical characterization and in vitro–in silico lung deposition results /

Elmentve itt :

Bibliográfiai részletek
Szerzők:	Benke Edit Farkas Árpád Balásházy Imre Révész Piroska Ambrus Rita
Dokumentumtípus:	Cikk
Megjelent:	2019
Sorozat:	DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY 45 No. 8
doi:	10.1080/03639045.2019.1620268
mtmt:	30729386
Online Access:	http://publicatio.bibl.u-szeged.hu/17229

Hasonló tételek

Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties
Szerző: Ambrus Rita, et al.
Megjelent: (2018)

Development of novel formulated ciprofloxacin hydrochloride containing dry powder inhalation system
Szerző: Benke Edit
Megjelent: (2023)

Formulation and In Vitro and In Silico Characterization of “Nano-in-Micro” Dry Powder Inhalers Containing Meloxicam
Szerző: Party Petra, et al.
Megjelent: (2021)

Formulation of a combined dry powder inhalation therapy for cystic fibrosis
Szerző: Banat Heba, et al.
Megjelent: (2022)

Formulation and investigation of novel, carrier-based dry powder inhalation system
Szerző: Benke Edit, et al.
Megjelent: (2019)

The Effect of Ethanol on the Habit and in vitro Aerodynamic Results of Dry Powder Inhalation Formulations Containing Ciprofloxacin Hydrochloride
Szerző: Benke Edit, et al.
Megjelent: (2021)

Development of an Innovative, Carrier-Based Dry Powder Inhalation Formulation Containing Spray-Dried Meloxicam Potassium to Improve the In Vitro and In Silico Aerodynamic Properties
Szerző: Benke Edit, et al.
Megjelent: (2020)

Formulation and aerodynamic evaluation of carrier-free dry powder inhalation systems containing meloxicam
Szerző: Chvatal Anita
Megjelent: (2019)

Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride
Szerző: Karimi Keyhaneh, et al.
Megjelent: (2017)

Carrier-free dry powder inhaler formulation for pulmonary delivery insights into stability, safety, and aerodynamic performance : [abstract] /
Szerző: Banat Heba, et al.
Megjelent: (2025)

Development and formulation of a single dry powder inhaler combining ketoprofen nanoparticlesembedded mannitol microparticles for pulmonary inflammations in vitro and in silico analysis, and cell line assessment : [absztrakt] /
Szerző: Banat Heba, et al.
Megjelent: (2024)

Development of meloxicam potassium-containing co-spray-dried inhalation powder with sodium stearate
Szerző: Benke Edit, et al.
Megjelent: (2021)

Optimizing aerodynamic performance of an antiinflammatory containing dry powder inhaler via nano-spray drying [abstract] /
Szerző: Banat Heba, et al.
Megjelent: (2024)

Development and evaluation of levofloxacin dry powder for inhalation [abstract] /
Szerző: Soliman Lomass, et al.
Megjelent: (2026)

Development of a chlorpromazine containing dry powder inhaler for targeting systemic effect [abstract] /
Szerző: Piszman Zsófia Ilona, et al.
Megjelent: (2026)

Stability study of nasal powder formulation containing nanosized lamotrigine
Szerző: Gieszinger Péter, et al.
Megjelent: (2020)

Development of meloxicam containing carrier-free "nano-in-micro" dry powder inhaler systems
Szerző: Party Petra
Megjelent: (2024)

Preparation and characterization of carrier-free dry powder inhalers containing nanosized active ingredient
Szerző: Party Petra, et al.
Megjelent: (2021)

New aspects of developing a dry powder inhalation formulation applying the quality-by-design approach
Szerző: Pallagi Edina, et al.
Megjelent: (2016)

A Novel Combined Dry Powder Inhaler Comprising Nanosized Ketoprofen-Embedded Mannitol-Coated Microparticles for Pulmonary Inflammations Development, In Vitro–In Silico Characterization, and Cell Line Evaluation /
Szerző: Banat Heba, et al.
Megjelent: (2024)

Development of a combined nanosystem as a dry powder inhaler for the treatment of pulmonary inflammations [abstract] /
Szerző: Banat Heba, et al.
Megjelent: (2023)

Stability and In Vitro Aerodynamic Studies of Inhalation Powders Containing Ciprofloxacin Hydrochloride Applying Different DPI Capsule Types
Szerző: Benke Edit, et al.
Megjelent: (2021)

Process development of inhalation powders containing simvastatin loaded liposomes using spray drying technology
Szerző: Barbălată Cristina-Ioana, et al.
Megjelent: (2024)

High-dose ibuprofen containing carrier-free dry powder inhalers for the therapy of cystic fibrosis [abstract] /
Szerző: Party Petra, et al.
Megjelent: (2023)

Formulation of levodopa containing dry powder for nasal delivery applying the quality-by-design approach.
Szerző: Bartos Csilla, et al.
Megjelent: (2018)

Formulation of meloxicam potassium-containing, cyclodextrin-based nasal powders via spray drying
Szerző: Varga Patricia Orsolya
Megjelent: (2025)

Cytotoxicity of inhalable dry powders in A459 human lung cancer cell line
Szerző: Chvatal Anita, et al.
Megjelent: (2018)

Development of dry powder inhalation systems using ciprofloxacin hydrochloride new aspects of formulation by means of quality by design approach /
Szerző: Karimi Keyhaneh
Megjelent: (2019)

Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach
Szerző: Karimi Keyhaneh, et al.
Megjelent: (2016)

Characterization of dry powder inhalation systems using an organic solvent to reach special micrometric properties
Szerző: Benke Edit, et al.
Megjelent: (2020)

Optimized pulmonary delivery of theophylline using raffinose-based dry powder inhalers [abstract] /
Szerző: Soliman Lomass, et al.
Megjelent: (2025)

Formulation and investigation of ibuprofen containing inhalable nanocrystals to treat cystic fibrosis
Szerző: Party Petra, et al.
Megjelent: (2022)

Inhalable cyclosporine powder for immunosuppressive treatment
Szerző: D’Angelo Davide, et al.
Megjelent: (2021)

Inhalable ketoprofen nanocrystal-based dry powders for local and systemic pulmonary delivery A patient-centric approach /
Szerző: Banat Heba Fayez Mahmoud
Megjelent: (2025)

Spray dried hyaluronic acid nanoplexes conjugated with chitosan and its derivatives for the pulmonary administration as dry powder inhalers for tuberculosis
Szerző: Mukhtar Mahwash, et al.
Megjelent: (2021)

Preliminary study of nanonized lamotrigine containing products for nasal powder formulation
Szerző: Gieszinger Péter, et al.
Megjelent: (2017)

Dry powder inhaler of a miniprotein decoy for SARS-CoV-2 infection inhibition [abstract] /
Szerző: Glieca Stefania, et al.
Megjelent: (2023)

Development of isoniazid loaded nanotechnology-based dry powder pulmonary formulations for treatment of tuberculosis
Szerző: Mukhtar Mahwash
Megjelent: (2022)

A ready-to-use dry powder formulation based on protamine nanocarriers for pulmonary drug delivery
Szerző: Robla Sandra, et al.
Megjelent: (2023)

Formulation and investigation of bilayer tablets containing theophylline combined titanate nanotubes
Szerző: Kása Péter, et al.
Megjelent: (2010)